Transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction. TIA is one of the major risk factors for acute cerebral infarction.
1 In China, the annual incidence rate of TIA is about 180/100,000 accounting for 40% of ischemic stroke, which has been increasing per year and has become one of the major diseases that seriously impacts both human health and quality of life.
Nowadays, many domestic and international clinical guidelines for TIA have provided the basis of clinical practice for the treatment of TIA stratification, antiplatelet therapy, or diagnostic imaging.
2–4 An important research direction of TIA is how to more effectively transform TIA clinical guidelines into clinical practice. The implementation strategy based on the standardized clinical practice has provided a fundamental approach to transform medicine. The emergence of clinical pathway (CP) management supplies opportunities for the implementation and evaluation of developing the management for ischemic stroke.
As a new standardized management model of clinical diagnosis and a standard treatment modality and procedure, which have strict requirements of the work order and time, CP is made up by a team of professional staff (including physicians, clinical specialists, nurses, and hospital administrators, etc.), according to a need of clinical intervention of a particular disease. CP is conducive to implement standardized treatment, shorten average length of stay in hospitals, promote the rational use of medical resources, and ensure quality of care.
5–7 Foreign research showed the implementation of CP in the treatment of acute cerebral infarction can significantly shorten hospitalization time and hospital costs, promote efficient use of medical resources, decline the readmission rate, and improve clinical outcomes.
8–11 Today, there are fewer studies about the efficiency for organization management of TIA. Most studies pay attention to the stratified evaluation and referral processing mode.
12,13In China, the implementation of CP is at the beginning stage. Surgical diseases by surgical treatment are the major disease in view of implement of CP, and the management of CP for TIA patients is just beginning at 2010. The aim of this study was to assess the effectiveness, quality, and safety of implementation of CP for hospitalized TIA patients. The aim was also to determine whether a clear understanding of the medical duties and the implementation of a standardized treatment program could shorten the length of stay in hospitals, control medical costs, improve clinical efficiency of TIA, make rational use of medical resources, and improve medical quality.
Methods
Study Population
Xuanwu Hospital Capital Medical University is one of the first-class general hospitals and includes a neurology department. Xuanwu Hospital has more than 1,500 beds and about 2,000 patients with acute cerebral infarction are admitted to the neurology department, accounting for 45%−50% of the inpatients. As a pilot hospital of CP management, Xuanwu Hospital began to apply CP for TIA patients.
All participants were TIA patients from the neurology department during 2009 March to 2011 December and were managed with TIA CP. Inclusion criteria were 1) the principal diagnosis of TIA, including vertebral-basilar syndrome (ICD-10: G45.0) and carotid syndrome (cerebral hemisphere) (ICD-10: G45.1); and 2) treatment of patients according to CP when other diagnosis does not require special treatment or disrupt CP implementation. TIA patients before implication of CP (2008 May to 2010 February) were enrolled as controls.
TIA CP
TIA CP was designed by the Clinical Pathway Committee from the Ministry of Health prior to this study.
14 The Clinical Pathway Committee involved experts of multidisciplinary, including neurologists, neurosurgery scientists, nursing scientists, clinical pharmacists, experts in rehabilitation medicine, evidence-based medicine, hospital management, health economics and medical information, and other experts.
10,15–17 The Committee referred to the latest diagnosis and treatment guidelines and developed this evidence-based CP, including the Standard Admission Procedure and Clinical Pathways Document (Appendix I/II). CP was included in the routine clinical work of the neurology department as an element of medical quality improvement project. The leader of this CP implementation team is the director of neurology department. The team members include doctors, nurses, and other related medical staffs.
Each participant gave written informed consent and agreed to receive standard medical care including major medical advice, detail diagnosis, and treatment information within 1 week after admission. Detail diagnosis and treatment information were recorded using structured the TIA CP form (Appendix II) and entered into the database of the medical record statistics office. Nonconcurrent cohort method was used in this study. TIA information before and after implication of CP was collected from the medical record registration database and analyzed retrospectively.
Outcomes
The indicators for effect and safety of TIA CP included 1) length of stay; 2) hospital cost; and 3) indicators for safety (improvement rate, cerebral infarction, mortality, readmission rate (1 week, 2 weeks, 30 days because of cerebrovascular events, including TIA, cerebral infarction).
Statistical Analysis
Categorical variables were expressed as number (%) and continuous variables were expressed as mean±SD or median and quartiles. For comparison between groups, χ2/Fisher exact test and independent t-test/rank sum test were used for categorical and continuous variables, respectively. As nonconcurrent cohort method was used in this study, propensity score method was employed to avoid potential imbalance between the two groups. The variables included in the propensity score model were gender, age, cerebrovascular disease, hypertension, coronary heart disease, atrial fibrillation, diabetes, hyperlipidemia, smoking, drinking, ABCD2 score, risk classification, and method of admission. Adjusted baseline indicators were compared using logistic (qualitative indicators) and covariance analysis (quantitative indicators) between the groups, and propensity score was adjusted in the model as a continuous variable. Data analyses were performed by the SAS 9.13 (SAS Institute, Inc., Cary, NC). Significance was defined as p <0.05 (two-sided).
Results
Baseline Characteristics of Patients with Transient Ischemic attack
As shown in
Table 1, 284 patients with TIA were included in this study with 112 patients in the CP group and 179 patients in the NCP group. The mean age was 60.72±13.03 years and 62.11±12.64 years in the CP group and the NCP group, respectively. Both groups were similar with respect to mean age, gender proportion, and risk factors for angiosis (p >0.05). ABCD2 score was not statistically different between the CP group and the NCP group with mean score of 3.62±1.12 and 3.61±1.30 in both groups, respectively (p >0.05). Seventy-seven patients (68.75%) in the CP group were admitted to the hospital from the emergency department, and 35 (31.25%) from the outpatient department, whereas in the NCP group, 76.54% from emergency department and 23.46% from outpatient department. The proportion was not statistically significant (p >0.05).
Comparison of Cost and Medical Efficiency Indicators Before and After CP Implementation
The average length of stay was 9.55±3.89 days in the NCP group, and it was 7.26±2.09 days in the CP group. The average length of stay was significantly shortened by 2.29 days (p <0.001). Hospital cost in the CP group increased significantly by 7.9% (868 yuan) compared with that in NCP group (p <0.05). The median medication cost (P25, P75) was 4262.7(2856.7–5804.1) and 4200.0(3528.4–5179.1) in the CP group and the NCP group, respectively. The proportion of medication cost significantly decreased by 5% (p <0.05), whereas the proportion of examination cost significantly increased by 8% (p <0.001). In addition, examination cost using expensive machines also significantly increased by 4% (p <0.01).
As for the clinical outcomes of patients with TIA, 98.21% of the patients in the CP group was discharged in a good condition, whereas it was 97.77% in the NCP group; no significant difference was found between the improvement rate of the two groups (p >0.05). As shown in
Table 2, eight patients (4%) in the NCP group were admitted to the hospital because of a 30-day recurrent TIA or cerebral infarction, and four among them had cerebral infarction, whereas no recurrent TIA or cerebral infarction was found in the CP group at the 30-day follow-up.
Discussion
Increasing number of patients with cerebral infarction has been an important problem in China, and exploring better treatment has been a great challenge. Updated clinical guidelines have provided evidence for the transformation of research results on ischemic cerebrovascular disease into clinical practice.
19 Effective implementation strategy based on clinical practice is one of the fundamental pathways in translational medicine. The development of CP has provided a good opportunity for the optimal management of patients with ischemic stroke. It has been illustrated by other studies that the implementation of CP will reduce the length of stay, medication cost, examination cost, and the incidence of complications in hospital. In addition, it will also improve patients’ activities of daily living and medical quality.
11,19–21TIA is a critical and dangerous warning event of ischemic stroke, and it is also a major risk factor for cerebral infarction. Therefore, the prevention and treatment of TIA is very important. CP for patients with TIA is a good treatment model if expected results could be achieved. The feasibility assessment of emergency department-based TIA CP, which is reported by Brown, has shown that implementation of a CP is feasible and safe in an emergency department setting. However, the effect of CP in hospitalized patients with TIA has not been consistent.
As a pilot hospital of CP management in 2010, Xuanwu Hospital implemented CP management on patients with TIA in the neurology department. The objective of this project is to evaluate the effectiveness of TIA CP as a new medical care management pattern. The results have demonstrated that the length of stay has been reduced by 2.29 days, and the turnover rate has increased after the implementation of TIA CP. Therefore, the operational efficiency of the hospital has been improved, and the average waiting time of admission has been shortened. More patients could be better diagnosed and treated. The hospital cost increased by 7% after implementation of TIA CP. However, the average medication cost decreased, and the increment of hospital cost was mainly due to the increasing proportion of examination cost (increased by 8%).
Xuanwu Hospital is one of the first-class general hospitals and includes a neurology department. Because of the complex condition of patients in Xuanwu hospital, it is difficult to determine the treatment strategy of patients with TIA. Therefore, based on the
Standard Admission Procedure of Transient Ischemic Attack Clinical Pathways published by Health Ministry, the specific TIA CP of Xuanwu Hospital has been formulated after numerous discussions and expert debates. This evidence-based CP refers to the latest diagnosis and treatment guidelines of other countries
16–18 and includes some new examinations and treatment strategies. For example, transesophageal echocardiography and color Doppler flow imaging foaming test have become important examinations due to the relationship between patent foramen ovale and TIA. In addition, more and more patients need cerebral vascular angiography because of frequent TIA accompanied by cerebrovascular stenosis or cerebrovascular occlusion. The improvement of new technologies in medicine has offered not only more benefits but increased cost to patients. Therefore, examination costs increased after implementation of TIA CP.
CP substantially improves clinical practice guidelines and offers detailed procedures on treatment, examination, and medical order after admission. Physicians will not determine the diagnosis and treatment of TIA relying only on their own experiences. The implementation of TIA CP has indeed shortened length of stay, standardized clinical medication, and adjusted the distribution of hospital cost. The assessment of TIA CP effectiveness suggested that the examination cost should be further reduced. In general, the implementation of CP controlled the rapid growth of hospital cost to some extent and produced more reasonable distribution of hospital cost.
TIA, as an unstable high-risk state, is risk factor for early stroke. Many researches have shown that 8%−12% patients with TIA underwent cerebral infarction in 7 days, 9.2% patients in 30 days, and 10%−20% in 90 days.23,24 Because TIA most likely progresses to cerebral infarction in the initial days after TIA, early standard treatment will prevent the recurrence of stroke at best. Does the implementation of TIA CP reduce the risk of cerebral infarction? This study has found that the improvement rate of TIA in the CP group is similar with that in the NCP group; no recurrent TIA or cerebral infarction was found in the CP group, whereas eight patients (4%) in the NCP group were admitted to the hospital after a 14-day or a 30-day follow-up. It is possible that clinical effectiveness could not be observed because of short follow-up duration.
In conclusion, CP has standardized and normalized the diagnosis and treatment procedure of TIA. On one hand, the implementation of TIA CP will reduce unnecessary or unreasonable diagnosis and treatment, and improve the treatment result of physicians in different levels. On the other hand, it will also standardize the duration of fulfilling the diagnosis and treatment. CP not only provides a standard procedure for physicians to offer medical care, but also provides the best tool for diagnosis and treatment of TIA. Therefore, overtreatment will be controlled effectively, and medical resources will be better utilized.